Who
Fortress Biotech, Inc.
10% owner
Company insider
Files Form 4 as: 10% owner, Avenue Therapeutics; 10% owner, Mustang Bio; 10% owner, Checkpoint Therapeutics; 10% owner, Journey Medical; 10% owner, CB Pharma Acquisition.
In numbers
- Trades disclosed
- 48
- Buys
- 1
- Sells
- 2
- Bought
- $301K
- Sold
- $129K
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 18 Mar 2015
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | Avenue TherapeuticsBiotechnology | SEC FORM 4 Code A | —111,209 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | Avenue TherapeuticsBiotechnology | SEC FORM 4 Code A | —111,209 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | MBIO Mustang BioBiotechnology | SEC FORM 4 Code A | —278,385 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | MBIO Mustang BioBiotechnology | SEC FORM 4 Code A | —278,385 at $0.00 | filing |
| 29 Sep 2025filed 1 Oct 2025 | MBIO Mustang BioBiotechnology | SEC FORM 4 Code A | —59,334 at $0.00 | filing |
| 30 May 2025filed 3 Jun 2025 | Checkpoint Therapeuticsoption or derivative | SEC FORM 4 Code D | —700,000 at $0.00 | filing |
| 30 May 2025filed 3 Jun 2025 | Checkpoint Therapeutics | SEC FORM 4 Code D | $25.1M6,122,249 at $4.10 | filing |
| 29 May 2025filed 3 Jun 2025 | Checkpoint Therapeutics | SEC FORM 4 Sold | $129K100,000 at $1.29 | filing |
| 31 Mar 2025filed 2 Apr 2025 | MBIO Mustang BioBiotechnology | SEC FORM 4 Code A | —67,806 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | Avenue TherapeuticsBiotechnology | SEC FORM 4 Code A | —33,724 at $0.00 | filing |
| 26 Feb 2025filed 27 Feb 2025 | Checkpoint Therapeutics | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
| 1 Jan 2025filed 3 Jan 2025 | Checkpoint Therapeutics | SEC FORM 4 Code A | —2,386,808 at $0.00 | filing |
| 31 Dec 2024filed 3 Jan 2025 | Checkpoint Therapeutics | SEC FORM 4 Code A | —81,407 at $0.00 | filing |
| 27 Sep 2024filed 1 Oct 2024 | Checkpoint Therapeutics | SEC FORM 4 Code A | —146,341 at $0.00 | filing |
| 27 Jun 2024filed 28 Jun 2024 | MBIO Mustang BioBiotechnology | SEC FORM 4 Code A | —575,191 at $0.00 | filing |
| 16 Apr 2024filed 17 Apr 2024 | Avenue TherapeuticsBiotechnology | SEC FORM 4 Code A | —413,507 at $0.00 | filing |
| 20 Mar 2024filed 22 Mar 2024 | Checkpoint Therapeutics | SEC FORM 4 Code A | —193,905 at $0.00 | filing |
| 2 Jan 2024filed 3 Jan 2024 | Avenue TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,101,496 at $0.00 | filing |
| 2 Jan 2024filed 3 Jan 2024 | MBIO Mustang BioBiotechnology | SEC FORM 4 Code A | —419,092 at $0.00 | filing |
| 29 Dec 2023filed 3 Jan 2024 | Checkpoint Therapeutics | SEC FORM 4 Code A | —158,134 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.